Source: Yahoo

Pieris: Pieris Pharmaceuticals: Q3 Earnings Snapshot

BOSTON (AP) - BOSTON (AP) - Pieris Pharmaceuticals Inc. (PIRS) on Wednesday reported a loss of $2.9 million in its third quarter. On a per-share basis, the Boston-based company said it had a loss of $2.19. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PIRS at https://www.zacks.com/ap/PIRS

Read full article »
Annual Revenue
$25-100M
Employees
1-25
Stephen S. Yoder's photo - President & CEO of Pieris

President & CEO

Stephen S. Yoder

CEO Approval Rating

90/100

Read more